# The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome

> **NCT00990197** · NA · SUSPENDED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Transdermal nicotine patch

## Key facts

- **NCT ID:** NCT00990197
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Difficulties with enrollment.
- **Last updated:** 2009-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990197, "The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00990197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*